Effect of a chemical delivery system for dexamethasone (Dex-CDS) on peritumoral edema in an experimental brain tumor model.
Siegal
T
T
Neuro-Oncology Clinic, Hadassah Hebrew University Hospital, Jerusalem, Israel.
Soti
F
F
Biegon
A
A
Pop
E
E
Brewster
M E
ME
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001711:Biotransformation; D001812:Blood-Brain Barrier; D001923:Brain Chemistry / Q000187:drug effects; D001929:Brain Edema / Q000188:drug therapy* / Q000209:etiology; D001932:Brain Neoplasms / Q000150:complications / Q000503:physiopathology*; D003907:Dexamethasone / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016503:Drug Delivery Systems; D005070:Evans Blue; D005260:Female; D051381:Rats; D011916:Rats, Inbred F344; D013056:Spectrophotometry, Ultraviolet
D000893:Anti-Inflammatory Agents; D005070:Evans Blue; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone